AbbVie Trumps Q3 Earnings & Sales Estimates, Raises '24 EPS View

AbbVie Inc. (ABBV) reported adjusted earnings of $3.00 per share for the third quarter of 2024, beating the Zacks Consensus Estimate of $2.92. The reported earnings also exceeded the company's guidance of $2.88-$2.92 issued earlier this month. Earnings increased 1.7% year over year. ABBV's revenues of $14.46 billion also beat the Zacks Consensus Estimate of $14.28 billion. Sales rose 3.8% year over year on a reported basis and 4.9% on an operational basis. Revenues in third quarter were driven by robust sal ...